July 2025

Selective reporting and underrepresentation distort biomedical evidence, affecting pharmacy practice

VMAT2 inhibitors can improve movement symptoms.

Pharmacists are pivotal in optimizing GLP-1 receptor agonist therapy.

Omolola (Lola) A. Adeoye-Olatunde, PharmD, MS, discusses her passion for advancing community-engaged pharmacy research.

Critically ill patients treated with a pharmacist-managed insulin protocol achieved higher rates of glucose control than those treated with conventional methods.

GLP-1 compounding faces legal challenges, evolving FDA rules, and heightened enforcement risks.

Unique barriers can lead to psychiatric medication adherence rates as low as 26%.

Since the most recent guidelines were published, more evidence has emerged regarding intravenous corticosteroids for severely ill patients.

Finerenone emerges as a promising treatment for patients with diabetes and chronic kidney disease, significantly reducing cardiovascular and renal risks.

Innovative strategies are essential to recruit pharmacy students and transform practices, ensuring equitable access to pharmacy services in underserved areas.

Innovative pain management strategies emerge as experts advocate for personalized, multifaceted approaches to chronic pain, likening treatment to a tailored cupcake.

Building on positive low-density lipoprotein cholesterol (LDL-C)-lowering seen in patients with atherosclerotic cardiovascular disease, inclisiran was found to induce meaningful and sustained LDL-C reductions following recent acute coronary syndrome.